The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Therapeutic Preparations of Normal Polyspecific IgG (IVIg) Induce Apoptosis in Human Lymphocytes and Monocytes: A Novel Mechanism of Action of IVIg Involving the Fas Apoptotic Pathway
Abstract
Therapeutic preparations of normal human IgG for i.v. use (IVIg) exhibit a broad spectrum of immunoregulatory activities in vitro and in vivo. IVIg has been shown to inhibit the proliferation of activated B and T lymphocytes and of several autonomously growing cell lines. In this study, we demonstrate that IVIg induces apoptosis in leukemic cells of lymphocyte and monocyte lineage and in CD40-activated normal tonsillar B cells, involving, at least in part, Fas (CD95/APO-1) and activation of caspases. IVIg-induced apoptosis was higher in Fas-sensitive HuT78 cells than in Fas-resistant HuT78.B1 mutant cells, and soluble Fas inhibited IVIg-induced apoptosis. IVIg immunoprecipitated Fas from Fas-expressing transfectants and recognized purified Fas/glutathione-S-transferase fusion proteins upon immunoblotting. Affinity-purified anti-Fas Abs from IVIg induced apoptosis of CEM T cells at a 120-fold lower concentration than unfractionated IVIg. Inhibitors of cysteine proteases of the caspase family, caspase 1 (IL-1β-converting enzyme) and caspase 3 (Yama/CPP32b), partially inhibited IVIg-induced apoptosis of CEM cells. Furthermore, cleavage of poly(A)DP-ribose polymerase into an 85-kDa signature death fragment was observed in CEM cells following IVIg treatment. Thus, normal IgG induces apoptosis in lymphocytes and monocytes. Our results provide evidence for a role of Fas, bring new insights into the mechanisms of action of IVIg in autoimmune diseases, and suggest a role of normal Ig in controlling cell death and proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., & Henson, P. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2207 · Cited by 3,316
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Koopman, G., Reutelingsperger, C., Kuijten, G., Keehnen, R., Pals, S., & van Oers, M. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,681
Morgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Möller, P., Falk, W., Debatin, K.-M., & Krammer, P. H. (1989) · Science · doi:10.1126/science.2787530 · Cited by 1,716
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Protease activation during apoptosis: Death by a thousand cuts?
Martin, S. J., & Green, D. R. (1995) · Cell · doi:10.1016/0092-8674(95)90422-0 · Cited by 1,309
lpr And gld: Single Gene Models Of Systemic Autoimmunity And Lymphoproliferative Disease
Cohen, P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.243 · Cited by 1,196
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,107
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
Enari, M., Talanian, R. V., Wrong, W. W., & Nagata, S. (1996) · Nature · doi:10.1038/380723a0 · Cited by 964
A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen
Itoh, N., & Nagata, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82075-0 · Cited by 839
Involvement of an ICE-like protease in Fas-mediated apoptosis
Enari, M., Hug, H., & Nagata, S. (1995) · Nature · doi:10.1038/375078a0 · Cited by 734
Fehr, J., Hofmann, V., & Rappeler, U. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205273062102 · Cited by 708
Manipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection
Cavert, W., Notermans, D. W., Staskus, K., Wietgrefe, S. W., Zupancic, M., Gebhard, K., Henry, K., Zhang, Z.-Q., Mills, R., McDade, H., et al. (1997) · Science · doi:10.1126/science.276.5314.960 · Cited by 622
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis
Los, M., Craen, M. V. D., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Dröge, W., Krammer, P. H., Fiers, W., & Schulze-Osthoff, K. (1995) · Nature · doi:10.1038/375081a0 · Cited by 607
Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis
Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R., & Galluzzo, A. (1997) · Science · doi:10.1126/science.275.5302.960 · Cited by 582
Self-citationChapter 9 The End of the (Cell) Line: Methods for the Study of Apoptosis in Vitro
McGahon, A. J., Martin, S. J., Bissonnette, R. P., Mahboubi, A., Shi, Y., Mogil, R. J., Nishioka, W. K., & Green, D. R. (1995) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61929-9 · Cited by 573
Coutinho, A., Kazatchkine, M. D., & Avrameas, S. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80053-0 · Cited by 573
Self-citationTakahashi, A., Alnemri, E. S., Lazebnik, Y. A., Fernandes-Alnemri, T., Litwack, G., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., & Earnshaw, W. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8395 · Cited by 518
Purification and characterization of the Fas-ligand that induces apoptosis.
Suda, T., & Nagata, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.873 · Cited by 507
ICE Family Proteases: Mediators of All Apoptotic Cell Death?
Henkart, P. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80428-8 · Cited by 420
Cascino, I., Fiucci, G., Papoff, G., & Ruberti, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2706 · Cited by 397
Self-citationAPOPTOSIS AND DISEASE: Regulation and Clinical Relevance of Programmed Cell Death
M. Rudin, M., & B. Thompson, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.267 · Cited by 354
The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster
Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., Gibson, M., Davis-Smith, T., Smiths, C. A., Hunter, K., et al. (1994) · Immunity · doi:10.1016/1074-7613(94)90106-6 · Cited by 331
Regulation of apoptosis in the immune system
Krammer, P. H., Behrmann, I., Daniel, P., Dhein, J., & Debatin, K.-M. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90102-3 · Cited by 308
Cifone, M. G., Roncaioli, P., De Maria, R., Camarda, G., Santoni, A., Ruberti, G., & Testi, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00274.x · Cited by 290
Self-citationSchattner, E. J., Elkon, K. B., Yoo, D. H., Tumang, J., Krammer, P. H., Crow, M. K., & Friedman, S. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1557 · Cited by 278
Activation-induced apoptosis in lymphocytes
Green, D. R., & Scott, D. W. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90130-9 · Cited by 229
The Role of APO‐1‐Mediated Apoptosis in the Immune System
Krammer, P. H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., Westendorp, M. O., et al. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00889.x · Cited by 225
The role of the Caspase family of cysteine proteases in apoptosis
Miller, D. K. (1997) · Seminars in Immunology · doi:10.1006/smim.1996.0058 · Cited by 207
An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro
Papoff, G., Cascino, I., Eramo, A., Starace, G., Lynch, D. H., & Ruberti, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4622 · Cited by 201
Self-citationPoutsiaka, D., Clark, B., Vannier, E., & Dinarello, C. (1991) · Blood · doi:10.1182/blood.v78.5.1275.1275 · Cited by 199
Cascino, I., Papoff, G., De Maria, R., Testi, R., & Ruberti, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.13 · Cited by 169
Self-citationFas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis.
Tian, Q., Taupin, J., Elledge, S., Robertson, M., & Anderson, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.865 · Cited by 167
Pooled Human IgG Modulates Cytokine Production in Lymphocytes and Monocytes
Andersson, U., Björk, L., Skansén‐Saphir, U., & Andersson, J. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00855.x · Cited by 162
Abe, Y., Horiuchi, A., Miyake, M., & Kimura, S. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00854.x · Cited by 161
V Region‐Mediated Selection of Autoreactive Repertoires by Intravenous Immunoglobulin (i.v.Ig)
Kazatchkine, M. D., Dietrich, G., Hurez, V. J., Ronda, N., Bellon, B., Rossi, F., & Kaveri, S. V. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00858.x · Cited by 153
Self-citationVassilev, T. L., Gélin, C., Kaveri, S. V., Zilber, M., Boumsell, L., & Kazatchkine, M. D. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb03407.x · Cited by 120
Self-citationGossen, M., & Bujard, H. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.18.4411 · Cited by 111
Meier, T., Arni, S., Malarkannan, S., Poincelet, M., & Hoessli, D. C. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90165-4 · Cited by 97
Polyvalent immunoglobulin for intravenous use interferes with cell proliferationin vitro
van Schaik, I. N., Lundkvist, I., Vermeulen, M., & Brand, A. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00920789 · Cited by 81
Apoptosis in brain-specific autoimmune disease
Bauer, J., Wekerle, H., & Lassmann, H. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80057-3 · Cited by 63
IgG Induction of IL‐1 Receptor Antagonist Production by Human Monocytes
Arend, W. P., & Leung, D. Y. M. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00857.x · Cited by 63
Mountz, J. D., Zhou, T., Su, X., Wu, J., & Cheng, J. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0136 · Cited by 61
In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD
Pereira, B. J. G., Poutsiaka, D. D., King, A. J., Strom, J. A., Narayan, G., Levey, A. S., & Dinarello, C. A. (1992) · Kidney International · doi:10.1038/ki.1992.436 · Cited by 58
Ucker, D. S., Hebshi, L. D., Blomquist, J. E., & Torbett, B. E. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00893.x · Cited by 42
Baixerás, E., Boscá, L., Stauber, C., González-García, A., Carrera, A. C., Gonzalo, J. A., & Martínez‐A, C. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00883.x · Cited by 37
Lymphocyte Apoptosis ‐ Mechanisms and Implications in Disease
Howie, S., Harrison, D. J., & Wyllie, A. H. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00887.x · Cited by 36
Regulation of autoimmune response
Ridgway, W. M., Weiner, H. L., & Fathman, C. G. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90018-3 · Cited by 35
Mechanisms of Immunoglobulin Action: Observations on Kawasaki Syndrome and RSV Prophylaxis
Meissner, H. C., Schlievert, P. M., & Leung, D. Y. M. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00859.x · Cited by 29
Overview: Mechanisms of apoptosis
(1993) · Immunology Today · doi:10.1016/0167-5699(93)90213-5 · Cited by 22
Role of ICE-related and other proteases in Fas-mediated apoptosis.
Schulze‐Osthoff, K., Bauer, M. K., Vogt, M., & Łoś, M. (1996) · PubMed · Cited by 17
Auto-antibodies specific for β2 microglobulin in normal human serum
Vincent, C., & Revillard, J. (1983) · Molecular Immunology · doi:10.1016/0161-5890(83)90085-8 · Cited by 15
Cited by
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
Kazatchkine, M. D., & Kaveri, S. V. (2001) · New England Journal of Medicine · doi:10.1056/nejmra993360 · Cited by 1,209
Self-citationIntravenous immunoglobulin therapy: how does IgG modulate the immune system?
Schwab, I., & Nimmerjahn, F. (2013) · Nature Reviews Immunology · doi:10.1038/nri3401 · Cited by 820
Anti-Inflammatory Actions of Intravenous Immunoglobulin
Nimmerjahn, F., & Ravetch, J. V. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090232 · Cited by 525
Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Gelfand, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1009433 · Cited by 495
Convalescent plasma in Covid-19: Possible mechanisms of action
Rojas, M., Rodríguez, Y., Monsalve, D. M., Acosta-Ampudia, Y., Camacho, B., Gallo, J. E., Rojas-Villarraga, A., Ramírez-Santana, C., Díaz-Coronado, J. C., Manrique, R., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102554 · Cited by 491
Metadata
- Authors
- Prasad, N. K. A., Papoff, G., Zeuner, A., Bonnin, E., Kazatchkine, M. D., Ruberti, G., & Kaveri, S. V.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-10-01
- Volume
- 161
- Issue
- 7
- Pages
- 3781-3790
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1563183497
- Cited by
- 279
- References
- 57
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.